Hi Bill
I have spoken to management a few times and I do believe them to be extremely ethical.. infact, close to, if not the most ethical management team I have come across in my professional life.
I take it you dont share the same thoughts, which is fine by me... you are entitled to your own opinions.
I would like to ask though whether you have spoken to Denis and Co and/or spent much time with them?
Im sure Denis would be happy to meet with you and discuss your concerns.
Your comment: "If they wanted to save lives they would be conducting proper clinical trials and publishing enough detail in the company announcements for people to determine if their extracts actually do anything."
Im sorry but I have to completely disagree with this.
They have conducted something like 28 clinical trials in the 5 years they have been listed... far more than any other biotech on the ASX.
They have been able to do so largely because of the fact the trials have been conducted in Russia, where the costs are cheaper than in Oz and they are completed on time.
I dont see how you can argue that the company does not "want to save people's lives"?!?!
The fact that they have postponed the OTC release of BioA to instead focus on full pharmaceutical registration is another example.
I would like to know what your thoughts are on Professor's Zhebrun and Bespalov. I would surmise your credibility questions over Solagran as extending to these two gentlemen aswell...
As for the details of the trials, like I was saying to you in the posts the other day, we are going to hear alot more regarding trial results in peer review journal articles that will be published this year.
At this stage, the company appears to be focusing on satisfying (succesfully i should add) the requirements of regulatory bodies. We have Ropren registered as a pharmaceutical in Russia and BioA registered as a complementary medicine by the TGA.
What is to come??
WEll there is Ropren pharmaceutical registration in Europe, NDI status for BioA in the US, and also full pharmaceutical registration of BioA.
The regulatory approvals to date... and those they are seeking, will not be granted if, as you say there was a question as to whether "their extracts actually do anything"
Cheers
Livas1
- Forums
- ASX - By Stock
- SLA
- the alcholics trial
SLA
solara minerals ltd
Add to My Watchlist
0.00%
!
20.0¢

the alcholics trial, page-68
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.59M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 62269 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 0.200 |
1 | 14205 | 0.190 |
1 | 25000 | 0.185 |
1 | 25000 | 0.180 |
1 | 3000 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 62269 | 1 |
0.220 | 12510 | 2 |
0.240 | 60000 | 2 |
0.250 | 100000 | 1 |
0.260 | 117114 | 2 |
Last trade - 07.10am 18/07/2025 (20 minute delay) ? |
Featured News
SLA (ASX) Chart |
Day chart unavailable